Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Impurity Formula I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109485616B details a novel SFC purification method for Etodolac photodegradation impurities, ensuring 99% purity and stable supply for pharmaceutical quality control.
Patent CN104447447B reveals advanced impurity elimination methods for fulvestrant synthesis ensuring high purity and supply chain stability for pharmaceutical intermediates.
Novel high-purity synthesis of Bosutinib 1,3-propylene diether dimer impurity for QC. Simple route, >99% purity, scalable process for API manufacturers.
Novel synthesis of Relugolix intermediate impurity Formula VI via hydrolysis and cyclization. Enhances QC capabilities for API manufacturing.